Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
Maxim Group Starts Xplore Technologies (XPLR) at Buy
-
Solar Senior Capital (SUNS) Prices 4M Common Stock Offering at $16.76/Share
-
Solar Senior Capital Ltd. Announces Pricing of Public Offering of Common Stock
-
Medigus (MDGS) Prices 1.28M Registered Direct Offering at $1.15/ADS
-
Medigus Announces Pricing of $1.47 Million Registered Direct Offering
-
Solar Senior Capital (SUNS) Announces 4M Share Common Stock Offering
-
Solar Senior Capital Ltd. Commences Public Offering of Common Stock
-
Intec Pharma to Participate in Upcoming September Conferences
-
Notable Analyst Rating Changes 9/7: (LGND) (GLPI) (DIN) Upgraded; (MNTA) (OLN) (TNXP) Downgraded
-
Pre-Open Stock Movers 09/07: (RTRX) (AAOI) (FRAN) (CMG) Higher; (SFM) (HDS) (CASY) Lower (more...)
-
Maxim Group Downgrades Momenta Pharmaceuticals (MNTA) to Sell
-
Maxim Group Starts Coherus Biosciences (CHRS) at Buy
-
Provectus Biopharmaceuticals, Inc. Announces Closing of Public Offering
-
Generic EpiPen Pricing Parity and Less than 1% Share Supports $10 Adamis (ADMP) Target Price - Maxim Group
-
Sophiris Bio Closes Underwritten Public Offering
-
Provectus Biopharma (PVCT) Prices $6M Conv. Preferred Stock Offering
-
Provectus Biopharmaceuticals, Inc. Announces Pricing of Public Offering to Raise $6 Million
-
Maxim Group Downgrades HP, Inc. (HPQ) to Hold
-
Provectus Biopharma (PVCT) to Offer Common Stocks and Warrants
-
Stellar Acquisition III Inc. Completes $65,000,000 Initial Public Offering
-
Provectus Biopharmaceuticals, Inc. Announces Proposed Public Offering of Preferred Stock and Warrants
-
Maxim Group Downgrades Medivation (MDVN) to Hold Amid Takeover
-
Sophiris Bio (SPHS) Prices Common Stock, Warrants Offering for Proceeds of $26M
-
Sophiris Bio Prices Public Offering of Common Shares and Warrants
-
ImmunoCellular Therapeutics (IMUC) Tops Q2 EPS by 1c
-
ImmunoCellular Therapeutics Announces Second Quarter 2016 Financial Results
-
Stellar Acquisition III Inc. Announces Pricing of $65,000,000 Initial Public Offering
-
Unusual 11 Mid-Day Movers 8/18: (EARS) (CERU) (CXW) Higher; (SEMI) (CIE) (CSIQ) Lower
-
Notable Analyst Rating Changes 8/18: (PCLN) (KMI) (TOO) Upgraded; (TWTR) (HMSY) (MMP) Downgraded
-
Pre-Open Stock Movers 8/18: (SEMI) (CIE) (RPTP) Higher; (EARS) (CERU) (PTLA) Lower
-
Maxim Group Starts Digital Ally (DGLY) at Buy, $15 PT
-
Gladstone Land Corporation Announces Closing of Offering of 1,150,000 Shares of its 6.375% Series A Cumulative Term Preferred Stock for Gross Proceeds of Approximately $28.8 Million
-
Maxim Group Downgrades Popeyes Louisiana Kitchen (PLKI) to Hold
-
Maxim Group Downgrades Hain Celestial (HAIN) to Hold
-
Maxim Group Reiterates Buy on Celsion (CLSN) Following 2Q Report
-
Maxim Group Downgrades BioLineRx (BLRX) to Hold
-
Maxim Group Starts Onconova Therapeutics (ONTX) at Buy
-
Gladstone Land Corporation Prices Public Offering of 6.375% Series A Cumulative Term Preferred Stock
-
Seanergy Maritime Holdings Corp. Announces Completion of Registered Direct Offering
-
Gladstone Land Corporation Announces Preferred Stock Offering
-
Maxim Group Downgrades Redwood Trust (RWT) to Hold
-
Galena Biopharma (GALE) PT Cut to $1 at Maxim Group, Focus on GALE-401
-
CytoSorbents Achieves Fourth Consecutive Quarter of Record CytoSorb® Sales
-
Notable Analyst Rating Changes 8/9: (HL) (VALE) (DISH) Upgraded; (PACD) (INO) (WM) Downgraded
-
ImmunoCellular Therapeutics (IMUC) Prices 47M Share Stock Offering for Proceeds of $7.4M
-
ImmunoCellular Therapeutics Announces Pricing of $7.4 Million Public Offering
-
Kite Pharma (KITE) PT Trimmed to $77 at Maxim Group
-
Maxim Group Downgrades EverBank Financial (EVER) to Hold
-
Maxim Group Downgrades Inovio Pharmaceuticals (INO) to Hold
-
Check-Cap Ltd. Announces $5.9 Million Financing

